PITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models ...
Physician-scientist Dr. Latha Kiran Krishna Rajendran is advancing AI-driven precision oncology, predictive healthcare, ...
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors ...
Chemotherapy-induced nausea and vomiting (CINV) remains a significant barrier to treatment adherence and quality of life in cervical cancer patients receiving chemoradiotherapy. No validated ...
Certis Oncology, an AI-enabled translational science company, today announced the launch of Certis Oncology Intelligence®, an integrated platform designed to generate data-driven insights into ...
Before we begin, let me quickly remind you that during the course of this presentation, the company will make forward-looking statements. We caution you that any statement that is not a statement of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results